Financhill
Back

4D Molecular Therapeutics Vs. Louisiana-Pacific Industry Stock Comparison

Sell
35

FDMT
4D Molecular Therapeutics

Last Price:
24.00
Seasonality Move:
7.77%
Buy
67

LPX
Louisiana-Pacific

Last Price:
91.57
Seasonality Move:
0.7%
Sell
35
4D Molecular Therapeutics (FDMT) is a Sell

Is 4D Molecular Therapeutics a Buy, Sell or Hold?

  • The current 4D Molecular Therapeutics [FDMT] share price is $24.64. The Score for FDMT is 35, which is 30% below its historic median score of 50, and infers higher risk than normal.
  • FDMT is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
67
Louisiana-Pacific (LPX) is a Buy

Is Louisiana-Pacific a Buy, Sell or Hold?

  • The current Louisiana-Pacific [LPX] share price is $90.73. The Score for LPX is 67, which is 34% above its historic median score of 50, and infers lower risk than normal.
  • LPX is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

FDMT Stock Price Chart

What is 4D Molecular Therapeutics's stock price today?

  • The 4D Molecular Therapeutics share price today is $24.64
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and FDMT is experiencing slight buying pressure.

LPX Stock Price Chart

What is Louisiana-Pacific's stock price today?

  • The Louisiana-Pacific share price today is $90.73
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and LPX is experiencing buying pressure, which is a positive indicator for future bullish movement.

FDMT Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.46 Sell
Relative Strength Index (14 RSI): 43.49 Sell
Chaikin Money Flow: 167468 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (24.38 - 26.28) Sell
Bollinger Bands (100): (21.45 - 30.37) Sell

LPX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 3.31 Buy
Relative Strength Index (14 RSI): 64.37 Buy
Chaikin Money Flow: 748004 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (76.23 - 91.59) Buy
Bollinger Bands (100): (68.33 - 83.59) Buy

FDMT Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 25.14 Sell
20-day SMA: 25.64 Sell
50-day SMA: 27.04 Sell
200-day SMA: 20.06 Buy
8-day EMA: 24.96 Sell
20-day EMA: 25.39 Sell
50-day EMA: 25.96 Sell
200-day EMA: 22.33 Buy

LPX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 90.14 Buy
20-day SMA: 86.41 Buy
50-day SMA: 81.24 Buy
200-day SMA: 67.96 Buy
8-day EMA: 89.6 Buy
20-day EMA: 86.75 Buy
50-day EMA: 81.88 Buy
200-day EMA: 71.98 Buy

4D Molecular Therapeutics Earnings Growth & FDMT Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.18 per share, a decrease next quarter of $0.29 per share, a decrease this year of $0.48 per share, and a decrease next year of $0.20 per share.

Louisiana-Pacific Earnings Growth & LPX Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.28 per share, an increase next quarter of $0.25 per share, an increase this year of $2.55 per share, and a decrease next year of $0.17 per share.

4D Molecular Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Louisiana-Pacific Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):